BM
Bristol-Myers Squibb Company PFD CONV 2
BMYMP · OTC
$400.00 -57.46% (-$540.22)
Market Cap $814.6B
P/E Ratio 115.94x
Div. Yield 0.38%
ROE 25.85%
Bulios Fair Price
$459.19
14.8% upside
Trenutna cena
$400
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BMYMP trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
0 /100
Expensive P/B 14.60x
P/S 16.90x
P/E 115.94x
Growth
79 /100
Growing Book val. growth 15.56%
FCF growth 17.45%
EPS growth 13.64%
Profitability
97 /100
Strong FCF margin 31.75%
Op. margin 26.45%
Gross margin 63.15%
Quality
100 /100
Excellent Asset turnover 4.52x
ROA 66.09%
ROIC 90.34%
Debt
47 /100
Moderate Net debt/EBITDA -4.00x
Int. coverage 5.70x
Debt/Equity -0.81x
Stability
11 /100
Unstable Profitable years 0
EPS volatility 240.26%
Beta 0.27x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BMYMP
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Christopher S. Boerner
Employees
34,100
Headquarters
Princeton